I found the (brief) discussion by the R&D VP (Scott Seiwert) fairly informative for people like me who aren't as knowledgeable in the science. He talked about the various ways some of the HCV drugs are cleared. I thought he did that on the other call (Baird) but maybe I am mixing them up.
Market Data 
Markets 
AI
